BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6319877)

  • 1. Effect of human B-endorphin on the binding of different opiates to mouse brain membranes.
    Garzón J; Sánchez-Blázquez P; Lee NM
    Life Sci; 1983; 33 Suppl 1():279-82. PubMed ID: 6319877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate receptor binding profile in the rabbit cerebellum and brain membranes.
    Ho CL; Hammonds RG; Li CH
    Biochem Pharmacol; 1985 Apr; 34(7):925-31. PubMed ID: 2985086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional interactions of opioid peptides at mu and delta sites in rat brain.
    Hewlett WA; Barchas JD
    Peptides; 1983; 4(6):853-8. PubMed ID: 6324140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-endorphin does not protect alkylation of opiate receptor by N-ethylmaleimide.
    Westphal M; Hammonds RG; Ferrara P; Li CH
    Int J Pept Protein Res; 1985 Apr; 25(4):403-7. PubMed ID: 2991153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin-(1-13): the effect of in vivo treatment on opiate bindings in vitro.
    Jen MF; Garzon J; Loh HH; Lee NM
    Eur J Pharmacol; 1983 Jul; 91(1):95-9. PubMed ID: 6311575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
    Bowen WD; Kelemen M; Huey R; Stewart D
    NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide E: opiate receptor binding profile in the rat brain membrane assay. Comparison with beta-endorphin.
    Westphal M; Li CH; Heimer EP; Meienhofer J
    Biochem Biophys Res Commun; 1983 Aug; 114(3):1084-8. PubMed ID: 6311195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer analysis of the effect of beta-endorphin and dynorphin and related compounds on opioid binding to mouse brain membrane.
    Landahl HD; Garzon J; Lee NM
    Comput Biol Med; 1989; 19(3):151-62. PubMed ID: 2566453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes.
    Barrett RW; Vaught JL
    Life Sci; 1983 Dec; 33(24):2439-48. PubMed ID: 6316063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct subtypes of the opioid receptor with allosteric interactions in brain membranes.
    Demoliou-Mason CD; Barnard EA
    J Neurochem; 1986 Apr; 46(4):1118-28. PubMed ID: 3005504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):677-87. PubMed ID: 2993509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
    Chang KJ; Blanchard SG; Cuatrecasas P
    Mol Pharmacol; 1984 Nov; 26(3):484-8. PubMed ID: 6149459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
    Ishizuka Y; Oka T
    Tokai J Exp Clin Med; 1987 Mar; 12(1):11-7. PubMed ID: 2835832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics of dermorphin, and [dermorphin1-7]-beta c-endorphin in rat brain membranes.
    Westphal M; Hammonds RG; Li CH
    Peptides; 1985; 6(1):149-52. PubMed ID: 2986079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystamine-enkephalin dimer. Syntheses and biological activities of enkephalin analogs containing cystamine and cysteamine.
    Kondo M; Kodama H; Costa T; Shimohigashi Y
    Int J Pept Protein Res; 1986 Feb; 27(2):153-9. PubMed ID: 3009340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mu, delta, and kappa opiate binding sites in rat brain and spinal cord.
    Mack KJ; Killian A; Weyhenmeyer JA
    Life Sci; 1984 Jan; 34(3):281-5. PubMed ID: 6319937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.